Issued: December 2012.
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2012. Publication and catalogue information, links to buy online and reader comments.